Search Results 1441-1450 of 16287 for Nucleus

  1. Adrenal cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that begins in the adrenal glands. Find out about symptoms, diagnosis and treatment.

  2. A Study to Assess Feasibility and Benefit of a Patient-reported Outcomes Quality of Life Tool for Hematology and Medical Oncology - Mayo Clinic

    The purpose of this study is to determine the feasibility and benefit of a patient-reported outcomes quality of life tool for hematology and medical oncology.

  3. Nasal and paranasal tumors - Doctors and departments - Mayo Clinic

    Learn about these cancerous and noncancerous growths that form in and around the nose. Treatments include surgery, radiation and chemotherapy.

  4. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Spinal cord tumors can cause serious problems such as pain and paralysis. Find out about diagnosis and treatment.

  5. Skull base tumors - Doctors and departments - Mayo Clinic

    Skull base tumors are abnormal growths at the base of the skull that can be benign or cancerous and cause symptoms such as headaches, dizziness and ...

  6. Neurology - Clinical trials

    This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing neurocognitive ...

  7. Neurosurgery - Clinical trials

    Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6- ...

  8. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  9. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    Learn about the types of tumors that make up this group of rare cancers. Find out about symptoms, causes, diagnosis and treatments.

  10. Clinical trials - Oncology (Medical)

    After enrollment, patients will receive one cycle of Induction chemotherapy. Subsequent therapy will be based upon MIBG avidity and ALK status. Patients with ...